Search Results - "Mackie, deMauri S"

Prevalence of alopecia areata in Japan: Estimates from a nationally representative sample by Aranishi, Toshihiko, Ito, Taisuke, Fukuyama, Masahiro, Isaka, Yoshitaka, Mackie, DeMauri S., King‐Concialdi, Kristen, Senglaub, Steven S., Jaffe, Dena H., Shimomura, Yutaka, Ohyama, Manabu

“…Data on the prevalence of alopecia areata (AA) in Japan is limited and the epidemiology of the disease there is not well understood; therefore, it is critical…”
Get full text

Patient Preferences Influencing Treatment Decision-Making in Early-Stage Breast Cancer in Germany, Italy, and Japan by Flood, Emuella, McCutcheon, Susan, Beusterien, Kathleen, Mackie, deMauri S, Mokiou, Stella, Guillaume, Xavier, Mulvihill, Emily

“…Patients with early breast cancer (eBC) are increasingly provided with different options, which may involve a sequence of different treatments and treatment…”
Get full text

Negative Regulation of CARD11 Signaling and Lymphoma Cell Survival by the E3 Ubiquitin Ligase RNF181 by Pedersen, Sarah M., Chan, Waipan, Jattani, Rakhi P., Mackie, deMauri S., Pomerantz, Joel L.

“…NF-κB activation downstream of antigen receptor engagement is a highly regulated event required for lymphocyte activation during the adaptive immune response…”
Get full text

A global perspective in second‐line treatment patterns for patients with advanced esophageal squamous cell carcinoma by Jaffe, Dena H., Gricar, Joseph, DeCongelio, Marc, Mackie, deMauri S.

“…Background Esophageal cancer is a highly prevalent cancer associated with low survival, especially among those with advanced disease. Second‐line (2L)…”
Get full text

The burden of anxiety among a nationally representative US adult population by Kavelaars, RuthAnne, Ward, Haley, Mackie, deMauri S., Modi, Kushal M., Mohandas, Anita

“…Anxiety disorders are highly prevalent and are associated with a significant humanistic and economic burden. This study evaluates the impact of anxiety…”
Get full text

Evaluating Oncologists' Practice Patterns and Decision-Making in Locally Advanced or Metastatic Urothelial Carcinoma: The US Physician PARADIGM Study by Gupta, Shilpa, Costantino, Halley, Ike, Chiemeka, Gupta, Shaloo, Bhanegaonkar, Abhijeet, Su, Cathy, Thakkar, Sheena, Mackie, deMauri S, Devgan, Geeta, Katzenstein, Howard M, Liu, Frank X

“…The treatment landscape for locally advanced/metastatic urothelial carcinoma (la/mUC) has evolved. This study examined US prescribing patterns and clinical…”
Get full text

A Novel Approach to Computing Preference Estimates for Different Treatment Pathways: An Application in Oncology by Beusterien, Kathleen, Will, Oliver, Flood, Emuella, McCutcheon, Susan, Mackie, deMauri S., Mokiou, Stella

“…Background Patients with cancer may progress through multiple treatments with differing adverse effect profiles. Moreover, pathways may be fixed or flexible in…”
Get full text

Patient and neurologist preferences in the UK for relapsing-remitting multiple sclerosis treatments: findings from a discrete choice experiment by Tencer, Tom, Will, Oliver, Kumar, Jinender, Cambron-Mellott, M. Janelle, Mackie, deMauri S., Beusterien, Kathleen

“…To evaluate and compare patient and neurologist preferences for relapsing-remitting multiple sclerosis (RRMS) treatments with respect to benefits and risks…”
Get full text

Treatment Preferences Among Patients with Renal Cell Carcinoma: Results from a Discrete Choice Experiment by Ornstein, Moshe C, Rosenblatt, Lisa C, Yin, Xin, Del Tejo, Viviana, Guttenplan, Sarah B, Ejzykowicz, Flavia, Beusterien, Kathleen, Will, Oliver, Mackie, deMauri S, Skiles, Grace, DeCongelio, Marc

“…The treatment landscape for advanced/metastatic renal cell carcinoma (aRCC) has evolved quickly with the introduction of immunotherapies as a first-line…”
Get full text

Correction for Pedersen et al., Regulation of CARD11 Signaling and Lymphoma Cell Survival by the E3 Ubiquitin Ligase RNF181 by Pedersen, Sarah M, Chan, Waipan, Jattani, Rakhi P, Mackie, deMauri S, Pomerantz, Joel L

Get full text

Patient and Neurologist Preferences in the United States for Relapsing-Remitting Multiple Sclerosis Treatments: Findings from a Discrete Choice Experiment by Kumar, Jinender, Cambron-Mellott, M Janelle, Tencer, Tom, Will, Oliver, Mackie, deMauri S, Beusterien, Kathleen

“…Relapsing-remitting multiple sclerosis (RRMS) is a chronic inflammatory disease associated with central nervous system dysfunction and accelerated brain volume…”
Get full text

Patient Practices and Experiences During COVID-19 Among Individuals Across the United States Enrolled in MS LifeLines Patient Support Program (P1-1.Virtual) by Nicholas, Jacqueline, Mackie, deMauri S., Costantino, Halley, Lebson, Lori A., Mulvihill, Emily, Phillips, Amy L.

“…Abstract only…”
Get full text

A Cross-Sectional Survey Evaluating Cladribine Tablets Treatment Patterns Among Patients with Multiple Sclerosis Across the US Enrolled in the MS LifeLines Patient Support Program (P1-1.Virtual) by Nicholas, Jacqueline, Mackie, deMauri S., Costantino, Halley, Lebson, Lori A., Mulvihill, Emily, Phillips, Amy L.

“…Abstract only…”
Get full text

A multicountry chart review of treatment patterns and outcomes for patients with resected esophageal or gastroesophageal junction cancer by Singh, Prianka, Gricar, Joseph, Mackie, deMauri S, Xiao, Hong, DeCongelio, Marc, Jaffe, Dena H.

“…Abstract only 184 Background: Global neoadjuvant and adjuvant treatment patterns among patients with resected Esophageal Cancer (EC) and Gastroesophageal…”
Get full text

Disease management and frontline treatment of locally advanced or metastatic urothelial (la/mUC) carcinoma: The U.S. physician PARADIGM study by Gupta, Shilpa, Su, Cathy, Bhanegaonkar, Abhijeet, Gupta, Shaloo, Thakkar, Sheena, Mackie, deMauri S, Devgan, Geeta, Katzenstein, Howard, Liu, Frank

“…Abstract only 456 Background: The treatment landscape for la/mUC is evolving. Data on current real-world treatment trends in la/mUC are limited. This study…”
Get full text

Assessing treatment preferences among patients with advanced/metastatic renal cell carcinoma in the United States: A discrete choice experiment by Ornstein, Moshe Chaim, Rosenblatt, Lisa, Ejzykowicz, Flavia, Guttenplan, Sarah, Del Tejo, Viviana, Yin, Xin, Beusterien, Kathleen M., Mackie, deMauri S, Will, Oliver, Skiles, Grace, DeCongelio, Marc, Senglaub, Steven S.

“…630 Background: The introduction of immunotherapies has changed the first-line treatment landscape for advanced/metastatic renal cell carcinoma (aRCC). This…”
Get full text